[PDF] Top 20 1999 Update ACC AHA Guidelines Myocardial Infarction Exec Summary Circ Journal.pdf

... (ACC/AHA) Guidelines for the Management of Patients With Acute Myocardial Infarction have been reviewed over the past ...the Journal of the American College of Cardiology ... See full document

... randomized 12 562 patients with UA/STEMI who presented within 24 hours to placebo or clopidogrel (loading dose of 300 mg followed by 75 mg daily) and followed them for 3 to 12 months; all patients were given aspirin. ... See full document

... recurrent myocardial ischemia in patients under- going percutaneous coronary intervention, but no adequate studies have been published that specifically address this issue in patients who also require chronic ... See full document

... and intraoperative monitors is best left to the discretion of the anesthesia care team, which will consider the need for postoperative ventilation, cardiovascular effects (including myocardial depression), ... See full document

... Infarction trial [CAPTIM], which was performed after the meta-analysis) (173) demonstrated a 17% relative improvement in outcome associated with pre- hospital fibrinolytic therapy compared with in-hospital fibri- ... See full document

... low HDL cholesterol are at high risk for recurrent events and should be targeted for aggressive nonpharmacological treat- ment (dietary modification, weight loss, and/or physical exercise). ATP III does not specify a ... See full document

... Practice Guidelines; Canadian Cardio- vascular Society. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American ... See full document

... The ACC/AHA Task Force on Practice Guidelines makes every effort to avoid any actual or potential conflicts of interest that might arise as a result of an outside relationship or personal interest of ... See full document

... current update of the ACC/AHA/NASPE Guidelines for Implantation of Cardiac Pacemakers and Antiarrhyth- mia Devices includes several significant changes in the recommendations and in the ... See full document

... cardial Infarction), dofetilide may be considered as a second-line rather than a third-line antiarrhythmic agent, but that study involved selected post-myocardial infarction patients in whom the ... See full document

... Because CK-MB is found in the skeletal muscle and blood of healthy subjects, the cutoff value for an elevated CK-MB level is typically set a few units above the upper end of the reference (normal) range. In contrast, ... See full document

... The classification scheme recommended in this document represents a consensus driven by a desire for simplicity and clinical relevance. The clinician should distinguish a first- detected episode of AF, whether or not it ... See full document

... A indicates atrial; AP, accessory pathway; AT, atrial tachycardia; AV, atrioventricular; AVRT, atrio- ventricular reciprocating tachycardia; BBB, bundle-branch block; LBBB, left bundle-b[r] ... See full document

... the ACC/AHA Guidelines for Management of Patients with Acute Myocardial Infarction, whereas those without ST-segment elevation are managed with either ad- mission to the hospital or ... See full document

... upper limit of normal as having clinical significance. Thus a significant increase in CK-MB without Q-waves is consid- ered by most to qualify as an associated complication of PCI. If serial determinations are performed ... See full document

... sented to the initial receiving hospital or within 60 minutes com- pared to when fibrinolysis with a fibrin-specific agent could be initiated at the initial receiving hospital); or (3) fibrinolysis is administered and is ... See full document

... of AF represents a substantial achievement that promises better therapy for a large number of patients presently resistant to pharmacological or electrical conversion to sinus rhythm. The limited available studies ... See full document

... The committee conducted comprehensive searching of the scientific and medical literature on PCI, with special empha- sis on randomized controlled trials and meta-analyses pub- lished since 2001. In addition to ... See full document

... the guidelines, elective non-cardiac surgery should be optimally delayed 365 days after DES implan- ...and myocardial infarction, which was treated with antiplatelet and anticoagulation therapy that ... See full document

... Cardiac monitoring was first introduced nearly 60 years ago for critically ill patients, but today is used increasingly to monitor ED patients with a variety of conditions. Early monitoring focused on heart rate ... See full document